What is NRXP's P/E ratio?

NRX PHARMACEUTICALS INC (NRXP) currently trades at a P/E ratio of 471.86.

NRX PHARMACEUTICALS INC reports a Return on Equity (ROE) of 177.63%.

What is NRXP's dividend yield?

NRX PHARMACEUTICALS INC offers a dividend yield of 0.00%.

What is NRXP's Deepscope Quality Score?

Deepscope rates NRXP's overall financial quality at 54 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy NRXP?

Deepscope's AI Timing Score for NRXP is 87 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does NRXP belong to?

NRX PHARMACEUTICALS INC is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.

NRXP (NASDAQ) Stock Analysis | NRX PHARMACEUTICALS INC

Stock Check Daily update data at 9:30 AM
(Price: 2026-06-05 | FS: 2026-03-31)

NRXP

NRX PHARMACEUTICALS INC

US:NASDAQ STOCK Healthcare >> Biotechnology News 44

USD 4.14

0.09 (2.22%) Day Change

Watchlist Portfolio Compare Chart

471.86

P/E

-0.03

D/E

177.6%

ROE

-206.2%

ROA

0.00%

Div Yield

2.98

PEG

NRX PHARMACEUTICALS INC
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 4.14 Price 0.09 (2.22%) Day Change	NEWS SCORE: 44

NRXP, the overall quality is not quite good ( Quality = 54) but the timing to buy is ...(Sign In to See)...

Loading chart...

54 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: P/E ratio is relatively high
ROA is relatively low.
Acceleration of ROE growth rate is below our criteria.
ROA is too relatively low compare to ROE
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
Historical net profit margin is relatively low.

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Lorem ipsum dolor sit amet

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...

Quality Factors

48%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	44
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	4.14
PBV / Sector	-12.30 / 4.63
Earning Per Share	-0.60

PE / Sector	471.86 / 17.43
PEG or PE/Growth / Sector	2.98 / 0.53
Average 1M Daily Value	6.59 M
Average 1W Daily Value	10.12 M GREAT

Timing Factors

71%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

45%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Ability to Make Profit

52%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-1,070.26 / 449.48
NPM Average (%) / Sector	-1,703.37 / -1,506.49
NPM Change Average (%) / Sector	N/A / 4,940.99
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-206.17 / 30.58
ROA Average (%) / Sector	-336.29 / -347.17
ROA Change Average (%) / Sector	40.01 / 5,125.52 GREAT
ROE (%) / Sector	177.63 / -3.58 GREAT
ROE Average (%) / Sector	37.16 / 40.65 GREAT
ROE Change Average (%) / Sector	-35.22 / 2,109.80
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Return to Investors

Dividend (%) / Sector	N/A / 0.05
Dividend Average (%) / Sector	N/A / 16.49
Dividend Change Average (%) / Sector	N/A / 4.17

Registration Details

Analyze Date	2026-06-06 09:09:04
Symbol	NRXP
Name	NRX PHARMACEUTICALS INC
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	41.94 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	169.87 / 8,857.28

News, Concensus, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 1201 N. Market Street, Wilmington, DE, United States, 19801

Phone: 484 254 6134

Website: https://www.nrxpharma.com

Sector: Healthcare >> Biotechnology

Description: NRx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder (PTSD), and schizophrenia in the United States. It operates through NRx and Dura segments. The company develops NRX-101, an oral fixed-dose combination of D-cycloserine (DCS) and lurasidone in Phase 2/3 clinical testing for bipolar depression with sub-acute ideation and behavior; NRX-100, a preservative-free formulation of ketamine for intravenous infusion and for the treatment of suicidal depression; and KETAFREE, a generic preservative-free formulation of ketamine. It also provides precision-based interventional psychiatry services to patients with treatment-resistant depression and PTSD using a combination of neuroplastic drugs, transcranial magnetic stimulation (TMS), digital therapeutics, and hyperbaric therapy; ketamine infusion therapy; stellate ganglion blocks; Spravato administration; psychotherapy; and medication management. The company has a development and license agreement with Glytech LLC. NRx Pharmaceuticals, Inc. was founded in 2015 and is headquartered in Wilmington, Delaware.